Omnicell

An antidote to the norm


Listed on the Nasdaq stock exchange and based in Silicone Valley, Omnicell is recognised as one of the world’s leading providers of technologically-advanced automation for the acquisition, management, dispensary, and delivery of medications and supplies by healthcare providers.

Undertaking a variety of projects ranging from ambient decoration of its new Manchester headquarters and corporate literature to significantly more substantial engagements rooted in organisational strategy, the highest profile activity was creation of a brand identity for ‘Adherence’ which won industry-wide plaudits for it’s tackling of issues relating to the importance of taking medication correctly.